Jakob Dupont, EVP, Head of R&D at Atara Biotherapeutics, Inc. (ATRA), sold 10,000 shares at $16.01 ($160K) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $160k ATRA by EVP, Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 5,000 | $80K | 50.0% |
| 2 | $16.01 | 5,000 | $80K | 50.0% |
| Total | $16.01 avg | 10,000 | $160K | 100% |
| Filing → |
| ATRA | SELL | 2022-11-18 | $19K | — | Filing → |
| ATRA | SELL | 2022-08-18 | $21K | — | Filing → |
| ATRA | SELL | 2022-05-19 | $21K | — | Filing → |